trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['lung', 'destiny,lung01', 'astrazeneca']
tomorrow at #esmo22, we ll be sharing updated results from the destiny-lung01 phase ii trial in patients with non-small cell lung cancer whose tumors have an abnormal her2 gene. 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.